There are 594 resources available
427P - Postmarketing safety of anaplastic lymphoma kinase inhibitors: An analysis of selected adverse events in the EudraVigilance database
Presenter: Lea Knez
Session: Poster Display session
428P - Real-world effectiveness and cost-utility analysis of second-line immunotherapy for non-oncogene-addicted advanced non-small cell lung cancer
Presenter: Sasiporn Sawasdisara
Session: Poster Display session
429P - Real-world versus pathology panel-reviewed treatment outcomes in patients with stage IV LCNEC: A nationwide registry study
Presenter: Frank Heijboer
Session: Poster Display session
430P - Privacy-preserving LLMs for automated clinical feature extraction: A real-world study in NSCLC EGFR-mutated patients
Presenter: Laura Mazzeo
Session: Poster Display session
431P - Molecular testing practices for lung cancer: Survey insights from South Korean pathology laboratories
Presenter: Sehui Kim
Session: Poster Display session
432P - Real-world biomarker testing and treatment patterns in Belgian lung cancer patients: Insights from the AIBED study
Presenter: Lore Decoster
Session: Poster Display session
433P - Clinical characterization of tracheal and pulmonary adenoid cystic carcinoma: A French institutional experience
Presenter: Èlia Sais
Session: Poster Display session
434P - Clinicopathological Characteristics and Aggressive behavior of SMARCA4-Deficient undifferentiated thoracic tumors mimicking NSCLC: Data from a tertiary cancer center in India
Presenter: Nivedita Patnaik
Session: Poster Display session
435P - Inequities in anticancer drug access in neighboring countries in East Central and South-East Europe for the treatment of non-small cell lung cancer (NSCLC) patients
Presenter: Urska Janzic
Session: Poster Display session
436P - Demographics, clinical characteristics and treatment of lung cancer in a developing country: A pilot study in Malaysia
Presenter: Wen Xuan Lee
Session: Poster Display session